
|Videos|June 8, 2011
Dr. Infante on the Future of BRAF Inhibitors in Melanoma
Author(s)Jeffrey R. Infante, MD
Dr. Infante from Sarah Cannon Research Institute on the Future of BRAF Inhibitors in Melanoma
Advertisement
Jeffrey Infante, MD from Sarah Cannon Research Institute on the Future of BRAF Inhibitors in Melanoma
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
Hematologists Highlight Top Data From ASCO 2026
3
Subcutaneous Isatuximab Administered Via OBI Approved in EU for Multiple Myeloma
4
INDEPENDENCE, Type II JAK Inhibitor Data Highlight Key MPN and AML Data Arriving at EHA 2026
5






































































